Bayer announced an agreement to fully acquire Perfuse Therapeutics Inc., a biopharmaceutical company developing treatments for eye diseases, for up ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE